tenofovir has been researched along with Hyperparathyroidism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, JR; Esberard, EB; Lopes, PF; Lugon, JR; Medeiros, T; Mendes, GF; Patricio, JA; Silva, AA | 1 |
| Bano, G; Copas, AJ; Gedela, K; Hay, PE; Pakianathan, MR; Rosenvinge, MM; Sadiq, ST; Sheehy, CA; Wilkinson, A | 1 |
2 other study(ies) available for tenofovir and Hyperparathyroidism
| Article | Year |
|---|---|
Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D.
Topics: Adult; Albuminuria; Alkaline Phosphatase; Antiviral Agents; beta 2-Microglobulin; Creatinine; Cystatin C; Electrolytes; Female; Glomerular Filtration Rate; Hepatitis B; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Hormone; Renal Insufficiency; Serum Albumin; Tenofovir; Urea; Uric Acid; Vitamin D | 2016 |
Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency.
Topics: Adenine; Adult; Female; HIV Infections; HIV-1; Humans; Hyperparathyroidism; Male; Middle Aged; Organophosphonates; Parathyroid Hormone; Tenofovir; United Kingdom; Urban Population; Vitamin D; Vitamin D Deficiency | 2010 |